Medivation Announces Fourth Quarter and Year-End 2015 Financial Results Teleconference on February 25, 2016
(firmenpresse) - SAN FRANCISCO, CA -- (Marketwired) -- 02/11/16 -- Medivation, Inc. (NASDAQ: MDVN) today announced that it will host a live teleconference with management to discuss fourth quarter and year-end 2015 financial results and provide a general business update on February 25, 2016 at 4:30 p.m. Eastern Time. A press release for the fourth quarter and year-end of 2015 will be released after markets close on February 25, 2016.
Interested parties may listen to the live teleconference by calling 877-303-2523 from the U.S. or +1-253-237-1755 internationally. Individuals may access the live audio webcast by visiting:
Medivation, Inc. is a biopharmaceutical company focused on the development and commercialization of medically innovative therapies to treat serious diseases for which there are limited treatment options. Medivation aims to transform the treatment of these diseases and offer hope to critically ill patients and their families. For more information, please visit us at
Rick Bierly
Chief Financial Officer
(415) 543-3470
Anne Bowdidge
Sr. Director, Investor Relations
(650) 218-6900
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 11.02.2016 - 21:10 Uhr
Sprache: Deutsch
News-ID 450316
Anzahl Zeichen: 0
contact information:
Town:
SAN FRANCISCO, CA
Kategorie:
Drugs
Diese Pressemitteilung wurde bisher 401 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Medivation Announces Fourth Quarter and Year-End 2015 Financial Results Teleconference on February 25, 2016"
steht unter der journalistisch-redaktionellen Verantwortung von
Medivation (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
